| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.23 | 0.0009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |